XML 24 R12.htm IDEA: XBRL DOCUMENT
v3.20.4

STOCK-BASED COMPENSATION: | 9 Months Ended
--- | ---
Dec. 31, 2020
Equity [Abstract] |
STOCK-BASED COMPENSATION: | STOCK-BASED COMPENSATION: Stock-based Compensation Plans The Company has stock option and equity compensation plans for which a total of 42.3 million shares of the Company’s common stock have been reserved for issuance since the inception of the plans. At December 31, 2020, there were a total of 6.9 million shares available for future grants under the plans. Stock-based Compensation Expense The Company's stock-based compensation activity for the nine months ended December 31, 2020, by award type, was (dollars in millions):
|  | For the nine months ended
|  | December 31,
|  | 2020 |  | 2019
Stock options |  | $ | 1.9 |  |  | $ | 2.8 |
Restricted stock units |  | 40.5 |  |  | 40.5 |
Arbor acquisition consideration holdback |  | — |  |  | 2.6 |
DPM acquisition consideration holdback |  | 6.0 |  |  | 4.1 |
PDP assumed performance plan |  | 13.8 |  |  | 21.4 |
Acuity performance plan |  | 1.4 |  |  | — |
Other stock-based compensation |  | 1.0 |  |  | 0.9 |
Total non-cash stock-based compensation included in the condensed consolidated statements of operations |  | 64.6 |  |  | 72.3 |
Less expense related to liability-based equity awards |  | (19.7) |  |  | (23.3) |
Total non-cash stock-based compensation included in the condensed consolidated statements of equity |  | $ | 44.9 |  |  | $ | 49.0 |
The effect of stock-based compensation expense on income, by financial statement line item, was (dollars in millions):
|  | For the nine months ended
|  | December 31,
|  | 2020 |  | 2019
Cost of revenue |  | $ | 2.7 |  |  | $ | 2.8 |
Research and development |  | 21.0 |  |  | 17.3 |
Sales and marketing |  | 25.6 |  |  | 34.4 |
General and administrative |  | 15.3 |  |  | 17.8 |
Total non-cash stock-based compensation included in the condensed consolidated statements of operations |  | $ | 64.6 |  |  | $ | 72.3 |
The following table provides the expected future expense for all of the Company's outstanding equity awards at December 31, 2020, by award type. The amount for 2021 represents the remaining three months ending March 31, 2021. All other periods represent fiscal years ending March 31 (dollars in millions).
|  | For the years ending March 31,
|  | 2021 |  | 2022 |  | 2023 |  | 2024 |  | 2025 |  | Total
Stock options |  | $ | 0.3 |  |  | $ | 1.1 |  |  | $ | 0.3 |  |  | $ | — |  |  | $ | — |  |  | $ | 1.7 |
Restricted stock units |  | 59.4 |  |  | 42.9 |  |  | 43.9 |  |  | 24.1 |  |  | 4.4 |  |  | 174.7 |
DPM acquisition consideration holdback |  | 2.0 |  |  | 8.1 |  |  | 2.1 |  |  | — |  |  | — |  |  | 12.2 |
PDP assumed performance plan |  | 4.6 |  |  | 9.2 |  |  | — |  |  | — |  |  | — |  |  | 13.8 |
Acuity performance plan |  | 0.8 |  |  | 1.9 |  |  | 0.8 |  |  | 0.2 |  |  | — |  |  | 3.7 |
Other stock-based compensation |  | 0.6 |  |  | 0.4 |  |  | — |  |  | — |  |  | — |  |  | 1.0 |
|  | $ | 67.7 |  |  | $ | 63.6 |  |  | $ | 47.1 |  |  | $ | 24.3 |  |  | $ | 4.4 |  |  | $ | 207.1 |
Stock Options Activity Stock option activity for the nine months ended December 31, 2020 was:
|  |  |  |  |  | Weighted-average |  |
|  |  |  | Weighted-average |  | remaining |  | Aggregate
|  | Number of |  | exercise price |  | contractual term |  | Intrinsic value
|  | shares |  | per share |  | (in years) |  | (in thousands)
Outstanding at March 31, 2020 |  | 1,350,658 |  |  | $ | 14.43 |  |  |  |  |
Exercised |  | (524,085) |  |  | $ | 12.37 |  |  |  |  | $ | 22,271 |
Forfeited or canceled |  | (6,124) |  |  | $ | 5.24 |  |  |  |  |
Outstanding at December 31, 2020 |  | 820,449 |  |  | $ | 15.81 |  |  | 3.4 |  | $ | 47,075 |
Exercisable at December 31, 2020 |  | 783,303 |  |  | $ | 16.47 |  |  | 3.2 |  | $ | 44,431 |
The aggregate intrinsic value at period end represents the total pre-tax intrinsic value (the difference between LiveRamp’s closing stock price on the last trading day of the period and the exercise price for each in-the-money option) that would have been received by the option holders had they exercised their options on December 31, 2020. This amount changes based upon changes in the fair market value of LiveRamp’s common stock. A summary of stock options outstanding and exercisable as of December 31, 2020 was:
|  |  |  |  |  | Options outstanding |  | Options exercisable
Range of |  |  |  | Weighted-average |  | Weighted-average |  |  |  | Weighted-average
exercise price |  | Options |  | remaining |  | exercise price |  | Options |  | exercise price
per share |  | outstanding |  | contractual life |  | per share |  | exercisable |  | per share
$ | 0.61 |  |  | — |  | $ | 9.99 |  |  | 125,984 |  |  | 4.6 years |  | $ | 1.52 |  |  | 88,838 |  |  | $ | 1.32 |
$ | 10.00 |  |  | — |  | $ | 19.99 |  |  | 346,807 |  |  | 3.0 years |  | $ | 15.50 |  |  | 346,807 |  |  | $ | 15.50 |
$ | 20.00 |  |  | — |  | $ | 24.99 |  |  | 347,658 |  |  | 3.3 years |  | $ | 21.31 |  |  | 347,658 |  |  | $ | 21.31 |
|  |  |  |  |  | 820,449 |  |  | 3.4 years |  | $ | 15.81 |  |  | 783,303 |  |  | $ | 16.47 |
Restricted Stock Unit Activity Time-vesting restricted stock units ("RSUs") - During the nine months ended December 31, 2020, the Company granted RSUs covering 1,969,500 shares of common stock and having a fair value at the date of grant of $81.5 million. The RSUs granted in the current period vest over four years. Grant date fair value of these units is equal to the quoted market price for the shares on the date of grant. RSU activity for the nine months ended December 31, 2020 was:
|  |  |  | Weighted-average |  |
|  |  |  | fair value per |  | Weighted-average
|  | Number |  | share at grant |  | remaining contractual
|  | of shares |  | date |  | term (in years)
Outstanding at March 31, 2020 |  | 3,351,638 |  |  | $ | 40.68 |  |  | 2.51
Granted |  | 1,969,500 |  |  | $ | 41.36 |  |  |
Vested |  | (1,011,380) |  |  | $ | 41.43 |  |  |
Forfeited or canceled |  | (459,731) |  |  | $ | 41.35 |  |  |
Outstanding at December 31, 2020 |  | 3,850,027 |  |  | $ | 40.75 |  |  | 2.57
The total fair value of RSUs vested during the nine months ended December 31, 2020 was $53.4 million and is measured as the quoted market price of the Company's common stock on the vesting date for the number of shares vested. Performance-based restricted stock units ("PSUs") - Fiscal 2021 plans: During the nine months ended December 31, 2020, the Company granted PSUs covering 246,524 shares of common stock having a fair value at the date of grant of $10.7 million. The grants were made under two separate performance plans. Under the first performance plan, units covering 73,950 shares of common stock were granted having a fair value at the date of grant of $4.2 million, determined using a Monte Carlo simulation model. The units vest subject to attainment of market conditions established by the compensation committee of the board of directors (“compensation committee”) and continuous employment through the vesting date. The units may vest in a number of shares from 0% to 200% of the award, based on the total shareholder return of LiveRamp common stock compared to total shareholder return of the Russell 2000 market index for the period from April 1, 2020 to March 31, 2023. Under the second performance plan, units covering 172,574 shares of common stock were granted having a fair value at the date of grant of $6.5 million, which was equal to the quoted market price for the shares on the date of grant. The units vest subject to attainment of performance criteria established by the compensation committee and continuous employment through the vesting date. The units may vest in a number of shares from 0% to 200% of the award, based on the attainment of trailing twelve-month revenue growth and EBITDA margin targets for the period from April 1, 2020 to March 31, 2023. Performance will be measured and vesting evaluated on a quarterly basis beginning with the period ending June 30, 2021 and continuing through the end of the performance period. To the extent that shares are earned in a given quarter, 50% vest immediately and 50% vest on the one-year anniversary of attainment approval, except that all earned but unvested shares will vest fully at the end of the measurement period. Fiscal 2020 plans: During the first quarter of fiscal 2021, the compensation committee approved the final performance attainment on a fiscal 2020 performance plan covering 59,480 PSUs. The awards reached maturity of the relevant performance period at March 31, 2020, and final attainment of these awards was determined by the compensation committee during the quarter ended June 30, 2020 to be 164% resulting in an additional award of 38,063 units (for a total earned amount of 97,543 units). Of the earned amount, one-third vested immediately, while the remaining two-thirds will vest in equal increments in first quarters of fiscal years 2022 and 2023. Fiscal 2019 plans: The initial measurement date for the fiscal 2019 performance plan, covering 307,897 PSUs, was the period ended June 30, 2020. During the quarter ended September 30, 2020, the compensation committee approved performance measurements for the quarter ended June 30, 2020 totaling 57% attainment, resulting in a total earned amount of 178,146 units. Of the earned amount, one-half vested immediately, while the remaining one-half will vest one year later. The performance measurements occurring as of September 30, 2020 and December 31, 2020 resulted in no additional attainment. As of December 31, 2020, there remains a maximum potential of 437,648 additional units eligible for attainment under the plan. Quarterly measurements of attainment will continue through September 30, 2022. PSU activity for the nine months ended December 31, 2020 was:
|  |  |  | Weighted-average |  |
|  |  |  | fair value per |  | Weighted-average
|  | Number |  | share at grant |  | remaining contractual
|  | of shares |  | date |  | term (in years)
Outstanding at March 31, 2020 |  | 545,446 |  |  | $ | 51.01 |  |  | 2.24
Granted |  | 246,524 |  |  | $ | 43.40 |  |  |
Additional earned performance shares |  | 38,063 |  |  | $ | 55.48 |  |  |
Vested |  | (121,587) |  |  | $ | 48.88 |  |  |
Forfeited or canceled |  | (34,731) |  |  | $ | 34.94 |  |  |
Outstanding at December 31, 2020 |  | 673,715 |  |  | $ | 49.69 |  |  | 1.78
The total fair value of PSUs vested in the nine months ended December 31, 2020 was $6.1 million and is measured as the quoted market price of the Company’s common stock on the vesting date for the number of shares vested. Acquisition-related Performance Plan As part of the Company's acquisition of Acuity Data in July 2020, the Company will be obligated to pay up to an additional $5.1 million, settled in a variable number of shares of Company stock, and subject to certain performance conditions and continued employment of each participant. Performance will be measured and vesting evaluated in three annual increments on the anniversary of the closing date (which date may be changed by the board of directors to an earlier date). Through December 31, 2020, the Company had recognized a total of $1.4 million related to the plan. At December 31, 2020, the recognized, but unpaid, balance in other accrued expense in the condensed consolidated balance sheet was $1.4 million. Consideration Holdback As part of the Company's fiscal 2020 acquisition of Data Plus Math ("DPM"), $24.4 million of the acquisition consideration otherwise payable with respect to shares of DPM common stock held by certain key employees was subject to holdback by the Company pursuant to agreements with those employees (each, a "Holdback Agreement"). Each Holdback Agreement specifies that the consideration holdback will vest in three equal annual increments on the anniversary of the closing date (which date may be changed by the board of directors to an earlier date). Vesting is subject to the DPM key employees' continued employment through each annual vesting date and will be settled in shares of Company common stock. Through December 31, 2020, the Company had recognized a total of $12.2 million related to the DPM consideration holdback. At December 31, 2020, the recognized, but unpaid, balance related to the DPM consideration holdback in other accrued expenses in the condensed consolidated balance sheet was $4.1 million. The next annual settlement is expected to occur at the end of the first quarter of fiscal 2022. Pacific Data Partners ("PDP") Assumed Performance Plan In connection with the fiscal 2018 acquisition of PDP, the Company assumed the outstanding performance compensation plan under the PDP 2018 Equity Compensation Plan ("PDP PSU plan"). During fiscal 2020, the Company converted the outstanding PDP PSU plan to a time-vesting restricted stock plan ("PDP RSU plan"). Through December 31, 2020, the Company has recognized a total of $51.8 million related to the PDP RSU plan. At December 31, 2020, the recognized, but unpaid, balance related to the PDP RSU plan in other accrued expenses in the condensed consolidated balance sheet was $12.2 million.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration